Genesco Inc. Appoints New Directors, Adjusts Executive Compensation
Ticker: GCO · Form: 8-K · Filed: Jul 1, 2024 · CIK: 18498
Sentiment: neutral
Topics: board-changes, executive-compensation, governance
Related Tickers: GCO
TL;DR
Genesco adds 2 directors, rejiggers CFO pay. Board shakeup incoming?
AI Summary
Genesco Inc. announced on June 27, 2024, changes to its board of directors and executive compensation. The company elected two new directors, Mary N. Dillon and James A. Marcum, to its board, effective immediately. Additionally, the company entered into a new employment agreement with its Chief Financial Officer, Jonathan E. Wilson, effective June 27, 2024, detailing his compensation and benefits.
Why It Matters
The appointment of new directors and changes in executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate underlying issues or strategic shifts that may carry financial risks.
Key Players & Entities
- Genesco Inc. (company) — Registrant
- Mary N. Dillon (person) — Newly elected director
- James A. Marcum (person) — Newly elected director
- Jonathan E. Wilson (person) — Chief Financial Officer
- June 27, 2024 (date) — Effective date of board changes and employment agreement
FAQ
Who are the new directors appointed to Genesco Inc.'s board?
Mary N. Dillon and James A. Marcum were elected as new directors to Genesco Inc.'s board.
When were the new directors' appointments effective?
The appointments of Mary N. Dillon and James A. Marcum were effective as of June 27, 2024.
What is the significance of the new employment agreement for the CFO?
The new employment agreement for CFO Jonathan E. Wilson, effective June 27, 2024, outlines his compensation and benefits, indicating a formalization or update of his executive package.
What is Genesco Inc.'s principal executive office address?
Genesco Inc.'s principal executive offices are located at 535 Marriott Drive, Nashville, Tennessee 37214.
What is the filing date of this Form 8-K?
This Form 8-K was filed as of date July 1, 2024, reporting events from June 27, 2024.
Filing Stats: 584 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2024-07-01 09:00:27
Key Financial Figures
- $1.00 — nge on which registered Common Stock, $1.00 par value GCO New York Stock Exchan
Filing Documents
- gco-20240627.htm (8-K) — 35KB
- 0000950170-24-079286.txt ( ) — 142KB
- gco-20240627.xsd (EX-101.SCH) — 23KB
- gco-20240627_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GENESCO INC. Date: July 1, 2024 By: Scott E. Becker Scott E. Becker Senior Vice President, Secretary and General Counsel